Elan (Pharmaceuticals) Overview

  • Year Founded
  • 1969

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 900

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 8

  • Investments
  • 28

Elan (Pharmaceuticals) General Information

Description

Operator of a neuroscience-based biotechnology company. The company is organized into two business units, BioNeurology and Elan Drug Technologies enabling it to develop and manufacture innovative pharmaceuticals for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease and autoimmune diseases, including multiple sclerosis and Crohn's disease.

Contact Information

Website
www.elan.com
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Lincoln House, Lincoln Place
  • Dublin 2
  • Ireland
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Acquirer
Corporate Office
  • Lincoln House, Lincoln Place
  • Dublin 2
  • Ireland

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Elan (Pharmaceuticals) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Elan (Pharmaceuticals)‘s full profile, request access.

Request a free trial

Elan (Pharmaceuticals) Patents

Elan (Pharmaceuticals) Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2022121307-A Content switching device and information processing device Active 08-Feb-2021
JP-2025185109-A Content switching device, information processing device, information processing method, and information processing program Pending 08-Feb-2021
EP-2968995-A1 Inhibitors of lrrk2 kinase activity Active 15-Mar-2013
EP-2968995-A4 Inhibitors of lrrk2 kinase activity Active 15-Mar-2013
EP-2968995-B1 Inhibitors of lrrk2 kinase activity Inactive 15-Mar-2013 C07D417/12
To view Elan (Pharmaceuticals)’s complete patent history, request access »

Elan (Pharmaceuticals) Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Elan (Pharmaceuticals) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Elan (Pharmaceuticals)‘s full profile, request access.

Request a free trial

Elan (Pharmaceuticals) Investments & Acquisitions (28)

Elan (Pharmaceuticals)’s most recent deal was a Corporate with Quick Smart Wash for . The deal was made on 14-Jun-2022.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Quick Smart Wash 14-Jun-2022 Corporate Other Services (B2C Non-Financial)
Quick Smart Wash 13-Mar-2021 Corporate Other Services (B2C Non-Financial)
NewBridge Pharmaceuticals 29-May-2019 Later Stage VC Pharmaceuticals
Medikabazaar 29-Oct-2018 Early Stage VC Distributors (Healthcare)
Proteostasis Therapeutics 08-Sep-2015 Later Stage VC Drug Discovery
You’re viewing 5 of 28 investments and acquisitions. Get the full list »

Elan (Pharmaceuticals) Exits (11)

Elan (Pharmaceuticals)’s most recent exit was on 08-Sep-2015 from Proteostasis Therapeutics. The exit was categorized as with 10 buyers.

Company Name Exit Date Exit Type Exit Size Status Buyers
Proteostasis Therapeutics 08-Sep-2015 Completed
  • 10 buyers
Pharmaco (Michigan) 06-Jun-2012 Completed
Proteostasis Therapeutics 25-May-2011 Completed
Cognetix 08-Apr-2004 Completed
  • 6 buyers
Cognetix 29-Jan-2004 Later Stage VC Completed
  • 6 buyers
You’re viewing 5 of 11 exits. Get the full list »

Elan (Pharmaceuticals) Affiliates

Subsidiaries (2)

Name Industry Location Year Founded
AOP Health Vienna, Austria 1996
Alpex Pharma Mezzovico, Switzerland 1988

Elan (Pharmaceuticals) FAQs

  • When was Elan (Pharmaceuticals) founded?

    Elan (Pharmaceuticals) was founded in 1969.

  • Where is Elan (Pharmaceuticals) headquartered?

    Elan (Pharmaceuticals) is headquartered in Dublin, Ireland.

  • What is the size of Elan (Pharmaceuticals)?

    Elan (Pharmaceuticals) has 900 total employees.

  • What industry is Elan (Pharmaceuticals) in?

    Elan (Pharmaceuticals)’s primary industry is Pharmaceuticals.

  • Is Elan (Pharmaceuticals) a private or public company?

    Elan (Pharmaceuticals) is a Private company.

  • What is the current valuation of Elan (Pharmaceuticals)?

    The current valuation of Elan (Pharmaceuticals) is .

  • What is Elan (Pharmaceuticals)’s current revenue?

    The current revenue for Elan (Pharmaceuticals) is .

  • How much funding has Elan (Pharmaceuticals) raised over time?

    Elan (Pharmaceuticals) has raised $2.89B.

  • Who are Elan (Pharmaceuticals)’s investors?

    Atheneum Capital and Vertex Holdings have invested in Elan (Pharmaceuticals).

  • When was Elan (Pharmaceuticals) acquired?

    Elan (Pharmaceuticals) was acquired on 30-Jul-2013.

  • Who acquired Elan (Pharmaceuticals)?

    Elan (Pharmaceuticals) was acquired by Perrigo Company.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process